238 related articles for article (PubMed ID: 36217203)
1. SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain.
Wedel S; Mathoor P; Rauh O; Heymann T; Ciotu CI; Fuhrmann DC; Fischer MJM; Weigert A; de Bruin N; Hausch F; Geisslinger G; Sisignano M
J Neuroinflammation; 2022 Oct; 19(1):254. PubMed ID: 36217203
[TBL] [Abstract][Full Text] [Related]
2. SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators.
Wedel S; Hahnefeld L; Schreiber Y; Namendorf C; Heymann T; Uhr M; Schmidt MV; de Bruin N; Hausch F; Thomas D; Geisslinger G; Sisignano M
J Neuroinflammation; 2023 Jun; 20(1):149. PubMed ID: 37355700
[TBL] [Abstract][Full Text] [Related]
3. The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury.
Wedel S; Hahnefeld L; Alnouri MW; Offermanns S; Hausch F; Geisslinger G; Sisignano M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430751
[TBL] [Abstract][Full Text] [Related]
4. Nerve Excitability and Neuropathic Pain is Reduced by BET Protein Inhibition After Spared Nerve Injury.
Palomés-Borrajo G; Badia J; Navarro X; Penas C
J Pain; 2021 Dec; 22(12):1617-1630. PubMed ID: 34157407
[TBL] [Abstract][Full Text] [Related]
5. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.
Manjavachi MN; Costa R; Quintão NL; Calixto JB
Neuropharmacology; 2014 Apr; 79():17-27. PubMed ID: 24184386
[TBL] [Abstract][Full Text] [Related]
6. Nrf2/HO-1 signaling pathway participated in the protection of hydrogen sulfide on neuropathic pain in rats.
Chen H; Xie K; Chen Y; Wang Y; Wang Y; Lian N; Zhang K; Yu Y
Int Immunopharmacol; 2019 Oct; 75():105746. PubMed ID: 31325725
[TBL] [Abstract][Full Text] [Related]
7. Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel.
Huang YK; Lu YG; Zhao X; Zhang JB; Zhang FM; Chen Y; Bi LB; Gu JH; Jiang ZJ; Wu XM; Li QY; Liu Y; Shen JX; Liu XJ
Br J Pharmacol; 2020 Dec; 177(24):5642-5657. PubMed ID: 33095918
[TBL] [Abstract][Full Text] [Related]
8. Silencing of FKBP51 alleviates the mechanical pain threshold, inhibits DRG inflammatory factors and pain mediators through the NF-kappaB signaling pathway.
Yu HM; Wang Q; Sun WB
Gene; 2017 Sep; 627():169-175. PubMed ID: 28629826
[TBL] [Abstract][Full Text] [Related]
9. PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.
Guida F; Lattanzi R; Boccella S; Maftei D; Romano R; Marconi V; Balboni G; Salvadori S; Scafuro MA; de Novellis V; Negri L; Maione S; Luongo L
Pharmacol Res; 2015 Jan; 91():36-46. PubMed ID: 25434589
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the protein kinase IKKepsilon attenuates neuropathic pain in mice.
Möser CV; Möller M; Fleck SC; Thomas D; Geisslinger G; Niederberger E
Neuropharmacology; 2019 Mar; 146():198-211. PubMed ID: 30528326
[TBL] [Abstract][Full Text] [Related]
11. Preventive Intrathecal Injection of Bupivacaine Alleviated Microglia Activation and Neuropathic Pain in a Rat Model of Chronic Constriction Injury.
Wu CC; Chang CY; Tzeng CY; Huang JH; Hung CJ; Chen WY; Liao SL; Kuan YH; Chen CJ
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806200
[TBL] [Abstract][Full Text] [Related]
12. The stress regulator FKBP51: a novel and promising druggable target for the treatment of persistent pain states across sexes.
Maiarù M; Morgan OB; Mao T; Breitsamer M; Bamber H; Pöhlmann M; Schmidt MV; Winter G; Hausch F; Géranton SM
Pain; 2018 Jul; 159(7):1224-1234. PubMed ID: 29533388
[TBL] [Abstract][Full Text] [Related]
13. Duration of Reduction in Enduring Stress-Induced Hyperalgesia Via FKBP51 Inhibition Depends on Timing of Administration Relative to Traumatic Stress Exposure.
Wanstrath BJ; McLean SA; Zhao Y; Mickelson J; Bauder M; Hausch F; Linnstaedt SD
J Pain; 2022 Jul; 23(7):1256-1267. PubMed ID: 35296422
[TBL] [Abstract][Full Text] [Related]
14. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
[TBL] [Abstract][Full Text] [Related]
15. Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.
Chao PK; Lu KT; Lee YL; Chen JC; Wang HL; Yang YL; Cheng MY; Liao MF; Ro LS
PLoS One; 2012; 7(8):e43680. PubMed ID: 22937076
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.
Yang H; Wu L; Deng H; Chen Y; Zhou H; Liu M; Wang S; Zheng L; Zhu L; Lv X
J Neuroinflammation; 2020 May; 17(1):154. PubMed ID: 32393298
[TBL] [Abstract][Full Text] [Related]
17. Nerve Injury-Induced Neuronal PAP-I Maintains Neuropathic Pain by Activating Spinal Microglia.
Li J; Shi H; Liu H; Dong F; Liu Z; Lu Y; Chen L; Bao L; Zhang X
J Neurosci; 2020 Jan; 40(2):297-310. PubMed ID: 31744864
[TBL] [Abstract][Full Text] [Related]
18. Involvement of TRPM2 in peripheral nerve injury-induced infiltration of peripheral immune cells into the spinal cord in mouse neuropathic pain model.
Isami K; Haraguchi K; So K; Asakura K; Shirakawa H; Mori Y; Nakagawa T; Kaneko S
PLoS One; 2013; 8(7):e66410. PubMed ID: 23935822
[TBL] [Abstract][Full Text] [Related]
19. IKK/NF-κB-dependent satellite glia activation induces spinal cord microglia activation and neuropathic pain after nerve injury.
Lim H; Lee H; Noh K; Lee SJ
Pain; 2017 Sep; 158(9):1666-1677. PubMed ID: 28722693
[TBL] [Abstract][Full Text] [Related]
20. Role of the immune system in neuropathic pain.
Malcangio M
Scand J Pain; 2019 Dec; 20(1):33-37. PubMed ID: 31730538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
